Home > Compound List > Compound details
175481-36-4 molecular structure
click picture or here to close

(2R)-N-benzyl-2-acetamido-3-methoxypropanamide

ChemBase ID: 72595
Molecular Formular: C13H18N2O3
Molecular Mass: 250.29362
Monoisotopic Mass: 250.13174245
SMILES and InChIs

SMILES:
C(=O)([C@@H](COC)NC(=O)C)NCc1ccccc1
Canonical SMILES:
COC[C@H](C(=O)NCc1ccccc1)NC(=O)C
InChI:
InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1
InChIKey:
VPPJLAIAVCUEMN-GFCCVEGCSA-N

Cite this record

CBID:72595 http://www.chembase.cn/molecule-72595.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
(2R)-N-benzyl-2-acetamido-3-methoxypropanamide
IUPAC Traditional name
lacosamide
Synonyms
(2R)-N-benzyl-2-acetamido-3-methoxypropanamide
(R)-2-Acetamido-N-benzyl-3-methoxypropanamide
Erlosamide
Vimpat
Lacosamide
CAS Number
175481-36-4
MDL Number
MFCD08272557
PubChem SID
162037520
PubChem CID
219078

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID
PubChem 219078 external link

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 12.468967  H Acceptors
H Donor LogD (pH = 5.5) -0.022441661 
LogD (pH = 7.4) -0.022444889  Log P -0.022441605 
Molar Refractivity 67.5675 cm3 Polarizability 26.340395 Å3
Polar Surface Area 67.43 Å2 Rotatable Bonds
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Physical Property Safety Information Pharmacology Properties Product Information Bioassay(PubChem)
Hydrophobicity(logP)
0.392 expand Show data source
Storage Condition
-20°C expand Show data source
Target
Sodium channel expand Show data source
Purity
95% expand Show data source
95+% expand Show data source
Salt Data
Free Base expand Show data source

DETAILS

DETAILS

Selleck Chemicals Selleck Chemicals
Selleck Chemicals - S1253 external link
Research Area: Epilepsy, Fibromyalgia
Biological Activity:
Lacosamide is a medication developed for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. [1]Lacosamide is a functionalized amino acid that has activity in the maximal electroshock seizure test, like antiepileptic drugs that are believed to act through voltage-gated sodium channels. However, lacosamide does not act in a conventional way to stabilize fast sodium channel inactivation. Rather, it enhances slow inactivation.[1]Lacosamide does not affect AMPA, kainate, NMDA, GABAA, GABAB or a variety of dopaminergic, serotonergic, adrenergic, muscarinic or cannabinoid receptors and does not block potassium or calcium currents. [1]

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • http://en.wikipedia.org/wiki/Lacosamide
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle